Mapmygenome
PrivateLast Round
Pre Seed
Mar 10, 2015
Total Funding Raised
$1.1M
Company Overview
Mapmygenome operates in Healthcare & Life Sciences and is based in Hyderabad. Its latest recorded funding round was a Pre Seed round in March 2015.
Mapmygenome is a genomics company that provides personalized health solutions through at-home DNA tests and diagnostic genomic tests.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mapmygenome Comparables
Compare Mapmygenome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Positive Bioscience | 85% | |
| GenePoweRx | 83% | |
| Bione | 82% |
For institutional investors. Book with your work email.
Mapmygenome Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mapmygenome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Singapore Angel Network | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 36% MoM, reaching 46.1K.
- May 2, 2025
Monthly visitors grew 33% MoM, reaching 33.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_offices_toNov 3, 2026
Mapmygenome expands into North America by establishing an operation and laboratory in Canada, where approximately 60% of its operations are now based.
- acquiresOct 21, 2026
Mapmygenome completes its acquisition of dnaPower Inc. in Canada on Oct 21st '26, expanding its North American footprint in DNA, microbiome, longevity, and AI-driven multi-omics testing.
For institutional investors. Book with your work email.
Mapmygenome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mapmygenome's valuation, stock price, and market status.
Is Mapmygenome a public or private company?
Mapmygenome is a private company.
What is the current stock price of Mapmygenome?
Mapmygenome is a private company, so its shares have no public market price. Caplight tracks Mapmygenome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mapmygenome worth (valuation)?
Valuation information for Mapmygenome is not publicly available.
Can I buy Mapmygenome stock?
Mapmygenome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mapmygenome's last funding round?
Mapmygenome's most recent funding round was Pre Seed on March 10, 2015.
Who are the main investors in Mapmygenome?
Key investors in Mapmygenome include Singapore Angel Network.
Will Mapmygenome IPO soon?
No public IPO plans have been announced for Mapmygenome.
How can I track Mapmygenome secondary market activity?
Caplight tracks bids, offers, and trades in Mapmygenome's shares on secondary markets.